Akèy › Sakom Ewing
Etid klinik pou Sakom Ewing ap rekrite nan Etazini
33 etid pou Sakom Ewing ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- New York City, NY8 etid
- Houston, TX7 etid
- Philadelphia, PA7 etid
- Memphis, TN7 etid
- Boston, MA6 etid
- Los Angeles, CA6 etid
- Aurora, CO6 etid
- Washington, DC6 etid
- Birmingham, AL5 etid
- Atlanta, GA5 etid
- Gainesville, FL4 etid
- Phoenix, AZ4 etid
- Salt Lake City, UT4 etid
- St. Petersburg, FL4 etid
- Grand Rapids, MI4 etid
- Tampa, FL4 etid
- Nashville, TN4 etid
- Cincinnati, OH4 etid
- Columbus, OH4 etid
- Baltimore, MD4 etid
- Ann Arbor, MI3 etid
- Greenburgh, NY3 etid
- Dallas, TX3 etid
- Hartford, CT3 etid
- Miami, FL3 etid
- Harrisburg, PA3 etid
- St. Louis, MO3 etid
- San Francisco, CA3 etid
- Minneapolis, MN3 etid
- Orange, CA3 etid
- The Bronx, NY3 etid
Pa eta
- Alabama5 etid
- Arizona4 etid
- Colorado6 etid
- Connecticut4 etid
- Distrik Columbia6 etid
- Florid7 etid
- Georgia5 etid
- Kalifòni12 etid
- Maryland4 etid
- Massachusetts6 etid
- Michigan8 etid
- Minnesota5 etid
- Missouri4 etid
- New Jersey4 etid
- New York12 etid
- Ohio8 etid
- Pennsylvania10 etid
- Tennessee11 etid
- Texas9 etid
- Utah4 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
Ap rekriteFaz 1
Laj 1 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07194044Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
Ap rekriteFaz 1
Laj 2 ak plis · Tout sèks · Mizajou Sep 25, 2026 · NCT07297979Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Sep 17, 2026 · NCT06395103Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
Ap rekriteFaz 1
Laj 12 a 85 · Tout sèks · Mizajou Sep 8, 2026 · NCT03715933Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
Ap rekriteFaz 1/2
Jiska laj 26 · Tout sèks · Mizajou Sep 3, 2026 · NCT06465199Silmitasertib (CX-4945) in Combination With Chemotherapy for Relapsed Refractory Solid Tumors
Ap rekriteFaz 1/2
Jiska laj 30 · Tout sèks · Mizajou Sep 3, 2026 · NCT06541262Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Ap rekriteFaz 1
Laj 5 a 40 · Tout sèks · Mizajou Sep 3, 2026 · NCT06156410Lurbinectedin in FET-Fused Tumors
Ap rekriteFaz 1/2
Laj 10 ak plis · Tout sèks · Mizajou Sep 2, 2026 · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou Aug 25, 2026 · NCT04851119Integration of Adaptive Proton Therapy in Pediatric Solid Tumors and Hodgkin's Lymphoma
Ap rekrite
Tout laj · Tout sèks · Mizajou Aug 21, 2026 · NCT07514819Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)
Ap rekriteFaz 1
Laj 1 a 23 · Tout sèks · Mizajou Aug 13, 2026 · NCT07172958Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Aug 6, 2026 · NCT05210374Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Jul 31, 2026 · NCT07628634Targeted Oligometastatic Radiation in Pediatric and Young Adult Patients With Soft Tissue and Bone Sarcoma
Ap rekrite
Jiska laj 39 · Tout sèks · Mizajou Jul 13, 2026 · NCT06796543Eflornithine (DFMO) for Ewing Sarcoma and Osteosarcoma
Ap rekriteFaz 2
Laj 0 a 50 · Tout sèks · Mizajou Jul 9, 2026 · NCT07321912Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid Tumors
Ap rekriteFaz 1/2
6 Months – 25 Years · Tout sèks · Mizajou Jun 30, 2026 · NCT06625190XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT06571734Biologically-Adapted, Dose-Escalated Radiotherapy for the Treatment of Ewing Sarcoma, BEAR Trial
Ap rekrite
Laj 2 ak plis · Tout sèks · Mizajou Jun 4, 2026 · NCT07188532A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Ap rekriteFaz 1
Laj 16 ak plis · Tout sèks · Mizajou Jun 2, 2026 · NCT07197554B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)
Ap rekriteFaz 1
Jiska laj 21 · Tout sèks · Mizajou May 19, 2026 · NCT04897321Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
Ap rekriteFaz 1/2
12 Months – 30 Years · Tout sèks · Mizajou May 19, 2026 · NCT04901702Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
Ap rekriteEtid obsèvasyon
Laj 4 ak plis · Tout sèks · Mizajou Apr 17, 2026 · NCT03442465Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
Ap rekriteFaz 1
Laj 1 a 30 · Tout sèks · Mizajou Apr 15, 2026 · NCT04308330Single Arm Romiplostim to Prevent CIT
Ap rekriteFaz 1 bonè
Laj 1 ak plis · Tout sèks · Mizajou Mar 18, 2026 · NCT07048249Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Ap rekriteFaz 2
Laj 1 a 50 · Tout sèks · Mizajou Mar 13, 2026 · NCT01804634Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.